In Vitro Antifungal Activity of Sertaconazole Against 309 Dermatophyte Clinical Isolates

Journal of Chemotherapy

Volumn 15, Issue 6, 2003, Pages 555-557

  Carrillo Munoz A J ^a   Fernandez Torres, B ^b   Guarro, J ^b  

^a Associacio Catalana d'Intelligencia Artificial   (Spain)

^b UNIVERSITAT ROVIRA I VIRGILI   (Spain)

Author keywords

Antifungal; Dermatophyte moulds; Sertaconazole

Indexed keywords

ANTIFUNGAL AGENT; SERTACONAZOLE;

ANTIBIOTIC SENSITIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DERMATOPHYTE; EPIDERMOPHYTON FLOCCOSUM; FUNGAL STRAIN; FUNGUS ISOLATION; GEOMETRY; INCUBATION TIME; MICROSPORUM AUDOUINII; MICROSPORUM CANIS; MINIMUM INHIBITORY CONCENTRATION; MOULD; NONHUMAN; TEMPERATURE DEPENDENCE; TRICHOPHYTON RUBRUM; TRICHOPHYTON TONSURANS;

EID: 1242295245     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2003.15.6.555     Document Type: Article

References (12)

1. Ray MC, Gately LE. Dermatology manifestations of HIV infection in AIDS. Infect Dis Clin North Am 1994; 94: 583-605.
2. Agut J, Palacín C, Sacristán A, Ortiz JA. Inhibition of ergosterol synthesis by sertaconazole in Candida albicans. Arzn Forsch 1992; 42: 718-720.
3. Carrillo-Muñoz AJ, Tur-Tur C. Comparative study of antifungal activity of sertaconazole, terbinafine and bifonazole against clinical isolates of Candida spp., Cryptococcus neoformans and dermatophytes. Chemotherapy 1997; 43: 387-392.
4. Drohuet E, Dupont B. In vitro antifungal activity of sertaconazole. Arzn Forsch 1992; 42: 705-710.
5. Palacín C, Tarragó C, Sacristán A, Ortiz JA. Antifungal Activity of sertaconazole in the cutaneos retention time test. J Mycol Med 1995; 5: 35-39.
6. Palacín C, Tarragó C, Agut J, Guglietta A. In vitro activity of sertaconazole, fluconazole, ketoconazole, fenticonazole, clotrimazole and itraconazole against pathogenic vaginal yeast isolates. Methods Find Exp Clin Pharmacol 2001; 23: 61-64.
7. Prats G, Mirelis B, Palacín B, et al. Actividad antibacteriana in vitro de sertaconazol. Rev Esp Quimioter 1995; 8: 325-326.
8. Torres J, Márquez M, Camps F. Sertaconazole in the treatment of mycoses: from dermatology to gynecology. Int J Gynaecol Obstet. 2000; 71; Suppl 1: S3-20.
9. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi: approved standard. NCCLS document M38-A. National Committee for Laboratory Standards, Wayne, Pa, 2002.
10. Fernández-Torres B, Cabañes FJ, Abarca L, et al. Collaborative evaluation of optimal antifungal susceptibility testing conditions for dermatophytes. J Clin Microbiol 2002; 40: 3999-4003.
11. Grau MT, Romero A, Sacristán A, Ortiz JA. Dermal tolerance and phototoxicity studies of sertaconazole. Arzn Forsch 1992; 42: 746-7.
12. Agut J, Tarrida N, Sacristan A, Ortiz JA. Antiinflammatory activity of topically applied sertaconazole nitrate. Meth Find Exp Clin Pharmacol 1996; 18: 233-4.